Read + Share
Amedeo Smart
Independent Medical Education
Nowak RJ, Coffey CS, Goldstein JM, Dimachkie MM, et al. Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: The BeatMG Study. Neurology 2021 Dec 2. pii: WNL.0000000000013121.PMID: 34857535
Email
LinkedIn
Facebook
Twitter
Privacy Policy